









|
| �@ŠÖ“Œ˜A�‡ŽY‰È•w�l‰ÈŠw‰ï‰ïŽ� ƒIƒ“ƒ‰ƒCƒ“ƒWƒƒ�[ƒiƒ‹ |
<< Šw‰ïŽ�‚Ö–ß‚é
<< ‘O‚̃y�[ƒW‚Ö–ß‚é
�y“Á�W�z
ƒ�ƒ\ƒgƒŒƒLƒZ�[ƒg“Š—^’†‚ÉStevens-Johnson�ÇŒóŒQ‚ð’æ‚µ‚½“]ˆÚ�«�E�N“üŠï‘ق̈ê—á
—±—ˆ�@‘ñ, �²“¡�@”ü‹IŽq, “Þ—Ç�@ˆŸ‹MŽq, �¡ˆä�@ˆê�Í, �–Ø�@–Î, •�‹��@–ƒ‹I, ˆÀ“¡�@‹IŽq, �‚ˆÀ�@‹`�O, –Γc�@”Ž�s
‰¡•lŽs—§Žs–¯•a‰@ŽY•w�l‰È
Key words�FGestational trophoblastic disease, Stevens-Johnson syndrome, Methotrexate
“ú–{ŽY‰È•w�l‰ÈŠw‰ïŠÖ“Œ˜A�‡’n•û•”‰ï‰ïŽ�, 47(4)
459-463, 2010
|